Related by context. All words. (Click for frequent words.) 69 folate analogue metabolic 67 BLyS specific 67 inflammatory PDE 67 oral dihydropyrimidine dehydrogenase DPD 66 JAK#/JAK# 66 oral isoform selective HDAC 66 CYP#A# CYP#D# 66 reversible inhibitor 66 novel topoisomerase 66 cortisol synthesis 65 IAP inhibitor 65 AAG geldanamycin analog 65 CYT# potent vascular disrupting 65 pan histone deacetylase 65 sodium glucose cotransporter 65 receptor tyrosine kinase inhibitor 65 oral isotype selective HDAC 65 NS5b 64 NS5A replication complex 64 alpha folate receptor 64 oral Factor Xa 64 DNA methyltransferase inhibitors 64 highly selective inhibitor 64 certain protein tyrosine 64 virus HCV protease inhibitor 64 specific protein tyrosine 64 NS5B polymerase 64 non thiazolidinedione TZD 64 investigational HCV polymerase 64 mTOR kinase 64 PNP inhibitor 63 HCV NS5B polymerase 63 5 HT2A inverse 63 novel VDA molecule 63 selective adhesion molecule 63 multi kinase inhibitor 63 SGLT 2 63 proteasome inhibitor 63 non nucleoside HCV 63 HCV RNA polymerase 63 5 HT2A serotonin 63 CYP#A# isoenzyme 63 cyclin dependent kinase CDK 63 non nucleoside inhibitor 62 Janus kinase 62 cyclin dependent kinases CDKs 62 Angiotensin converting enzyme ACE 62 dasatinib Sprycel ® 62 inhibitor COX 62 triciribine phosphate monohydrate 62 signal transduction inhibitor 62 sphingosine 1 62 cytidine nucleoside analog 62 RAS MAPK pathway 62 glycoprotein GP IIb IIIa 62 HGS# 62 alvespimycin 62 CCR9 antagonist 62 PTP 1B 62 nilotinib Tasigna ® 62 metaglidasen 62 orally administered inhibitor 62 apoptosis proteins 62 oxidative stress inducer 62 triggers apoptosis programmed 62 VEGF receptors 62 statin HMG CoA reductase 62 humanised monoclonal antibody 61 potent topoisomerase II 61 Lenocta TM sodium stibogluconate 61 Talabostat 61 Epothilone D 61 PDE4 inhibitor 61 targeted alpha folate 61 delta selective PI3K 61 pertuzumab 61 selective inverse agonist 61 proteasome inhibitors 61 kinesin spindle protein KSP 61 IMPDH inhibitor 61 protein tyrosine phosphatase 1B 61 LymphoStat B belimumab 61 AEG# 61 Janus Kinase 61 MAGE A3 ASCI 61 imatinib Gleevec ® 61 liposomal formulation 61 modulates Akt 61 epothilones 61 mTOR mammalian target 61 ENMD # 61 FBPase 61 generation antisense inhibitor 61 cathepsin K inhibitor 61 evaluating tivozanib 61 centromere associated protein 61 vascular disrupting agents 61 E CENP E 61 MT# MEDI 61 novel histone deacetylase 61 PI3K/mTOR 61 reversible inhibitors 60 PSN# [002] 60 selective inhibitor 60 Omacetaxine 60 dipeptidyl peptidase IV 60 tubulin inhibitor 60 FOLFOX6 chemotherapy regimen 60 MKC# MT 60 JAK1 60 selective antagonist 60 investigational humanized monoclonal antibody 60 kidney urologic 60 bendamustine ifosfamide 60 Sudhir Agrawal D.Phil 60 Atrasentan 60 XL# anticancer compounds 60 HDACi 60 VEGF inhibitors 60 orally bioavailable 60 hypoxia activated prodrug 60 Archexin 60 dihydrofolate reductase 60 Vidofludimus 60 novel orally administered 60 JAK inhibitors 60 non peptidic protease 60 Aflibercept 60 cyclin dependent kinase inhibitor 60 DGAT 60 polymerase inhibitor 60 anti amnesic 60 agonistic human 60 multitargeted 60 ® C1 esterase 60 class mGluR5 inhibitor 60 Budesonide foam crofelemer 60 anti PlGF 60 histone deacetylase HDAC 60 Tumor necrosis factor 60 potently inhibit 60 lintuzumab SGN 60 TLR7 agonist 60 selective serotonin 2C receptor 60 BRAF kinase 60 HSP# inhibitor 60 neurokinin 1 60 mitogen activated ERK kinase 60 PF # [002] 60 Belimumab 60 Phase 1b clinical trials 60 rALLy clinical trial 60 IMiDs ® 60 secretory phospholipase A2 60 demonstrated antitumor activity 60 selectively inhibits 60 Serdaxin ® 60 small molecule tyrosine 60 anti miRs antisense oligonucleotide 60 aurora kinase 60 PEGylated Fab fragment 60 accumulate preferentially 60 thymidylate synthase 60 inverse agonist 60 next generation URAT1 59 prescribed proton pump 59 oral Janus kinase 59 AKT inhibitor 59 CCR2 receptor 59 IMiDs R 59 ALB # 59 Epothilones 59 phosphate S1P 59 MKC# MKC# PP 59 oral JAK1 59 antimitotic 59 inhibits Akt activation 59 oral nucleoside analogue 59 HCV polymerase inhibitors 59 cetuximab Erbitux R 59 generation FBPase inhibitor 59 histone deacetylase HDAC inhibitor 59 chemokine receptor 59 Silodosin 59 Blinatumomab 59 Akt activation 59 antibody MAb 59 peripherally restricted 59 evaluating T DM1 59 delta gamma agonist 59 radiation sensitizer 59 mitotic kinesin 59 Tyrima 59 endothelin receptor 59 BRAF inhibitor 59 brivanib 59 Phase Ib clinical trials 59 selective kinase inhibitor 59 CCR2 59 agent VDA 59 obatoclax 59 HGS ETR2 59 highly selective endothelin 59 cyclin dependent kinases 59 #HT# 59 dual PPAR peroxisome 59 kinesin spindle protein 59 TKB# 59 chimeric monoclonal antibody 59 PI3K/Akt pathway inhibitor 59 selective A2A adenosine receptor 59 generation Hsp# inhibitor 59 small molecule inhibitor 59 peptibody 59 antiinfectives called 59 humanized monoclonal antibody 59 histone deacetylase inhibitors 59 humanized therapeutic 59 selectively inhibited 59 castrate resistant prostate cancer 59 purine nucleoside phosphorylase PNP 59 peripherally acting 59 midstage clinical 59 THR beta agonist 59 potent inhibitor 59 methyl D aspartate 59 angiogenesis inhibitor 59 Crizotinib PF # 59 Aplidin 59 Alfacell proprietary ribonuclease 59 Annamycin 59 Romidepsin 58 5 HT4 58 Aurora Kinase 58 Pruvel TM 58 oral prodrug 58 small molecule Hedgehog 58 histone deacetylase inhibitor 58 MCSP respectively 58 5 HT6 receptor 58 elotuzumab 58 TLK# 58 CD4 monoclonal antibody 58 dasatinib Sprycel 58 Rigel R# 58 hypoxia inducible factor 58 activin receptor type 58 endothelin receptor antagonists 58 visilizumab 58 Integrase inhibitors 58 cutaneous T 58 receptor inhibitor 58 fostamatinib 58 targeting CD# 58 receptor agonist 58 Ceflatonin R 58 investigational hepatitis C 58 sulfonylhydrazine class 58 specific lectin receptors 58 Enzastaurin 58 Hsp# inhibitors 58 5 HT2A receptor 58 receptor antagonists 58 tramiprosate Alzhemed TM 58 CCR5 antagonist 58 adecatumumab MT# 58 Sapacitabine 58 oral proteasome inhibitor 58 Hsp# chaperone system 58 Tumor Necrosis Factor 58 selective immunoproteasome inhibitor 58 Crizotinib 58 vascular disrupting agent 58 beta 1a 58 candidate DB# 58 erlotinib Tarceva ® 58 MET VEGFR2 58 PANVAC VF 58 gemcitabine Gemzar ® 58 HCV protease inhibitors 58 docetaxel Taxotere R 58 selective modulator 58 calcitonin gene related 58 potently inhibited 58 3 kinase PI3K 58 KSP inhibitor 58 Lenocta TM 58 pan HDAC inhibitor 58 FLT3 58 phase IIb study 58 melanocortin receptor agonists 58 poly ADP ribose polymerase 58 OMP #M# 58 cyclooxygenase 58 MEK inhibitors 58 CDK cyclin dependent 58 SinuNase ™ 58 HCV protease 58 Elesclomol 58 Aurora kinase inhibitor 58 RhuDex ® 58 candidate deforolimus 58 HIV integrase inhibitor 58 active AKT inhibitor 58 Pruvel ™ 58 oral antiviral 58 sorafenib Nexavar 58 sunitinib malate 58 GW# [003] 58 antiangiogenesis therapies 58 Tarceva TM 58 nucleoside analogue 58 specific neuronal nicotinic 58 methionine aminopeptidase 58 receptor modulators 58 selective estrogen receptor modulator 58 receptor CXCR4 58 mGluR2 NAM 58 clinical trials Archexin 58 anti CD3 monoclonal 58 selective estrogen receptor 57 HCD# [002] 57 mGluR5 negative 57 selectively inhibit replication 57 Elvitegravir 57 NOX4 57 histone deacetylase 57 TRIOLEX HE# APOPTONE HE# 57 delta isoform 57 Synavive 57 seliciclib CYC# 57 GVAX ® 57 Temsirolimus 57 trastuzumab Herceptin R 57 PDE# 57 Tofacitinib 57 Fc fusion protein 57 JAK inhibitor 57 epothilone 57 Raf kinase 57 cilengitide 57 serine threonine 57 Cloretazine R 57 gefitinib Iressa 57 CDK4 57 initiated Phase Ib 57 Personalized Immunotherapy 57 Ep CAM 57 Mg Uk 57 histone deacetylase HDAC inhibitors 57 OXi# 57 panitumumab Vectibix 57 dipeptidyl peptidase 4 57 CB2 receptor selective 57 PI3 kinase 57 RAF kinase 57 IMC #B 57 Xanafide 57 Tarvacin TM 57 BMS # 57 phosphoinositide 3 57 fusion inhibitor 57 Symadex 57 Hsp# inhibitor 57 IL-#/# 57 Delta opioid receptor 57 Aurora kinase 57 CD# antibody [002] 57 progressive metastatic prostate 57 R roscovitine 57 Panzem R NCD 57 beta secretase inhibitors 57 metabotropic glutamate receptor 57 Crofelemer budesonide foam 57 RhuDex R 57 Sphingomab 57 alpha 2A 57 5alpha reductase 57 non porcine pancreatic 57 HDAC enzymes 57 midstage trials 57 oral ghrelin agonist 57 fosbretabulin 57 ALK inhibitor 57 Bayer HealthCare Onyx Pharmaceuticals 57 NS5A 57 MEK ERK 57 protein kinase inhibitor 57 GGTase 57 MEK inhibitor 57 nucleoside analog 57 tanespimycin 57 paclitaxel Taxol 57 M1 muscarinic 57 activate SIRT1 57 ADP receptor antagonist 57 CCR5 antagonists 57 kinase inhibitors 57 PEGylated anti 57 Phase IIb trials 57 targeting miR 57 IMC A# 57 luteinizing hormone releasing 57 receptor partial agonist 57 multicenter Phase II 57 cyclooxygenase 2 57 PRT# 57 LymphoStat B TM 57 refractory chronic lymphocytic 57 CCX# 57 neuro inflammatory 57 angiotensin receptor 57 alkylating agent 57 Telintra 57 taxane derivative 57 Epratuzumab 57 oral rivaroxaban 57 cell lymphoma CTCL 57 Panzem NCD 57 inhibitor 57 otelixizumab 57 Vicinium TM 57 Ocrelizumab 57 SGLT2 inhibitor 57 IGF1R 57 JAK2 Inhibitor 57 TNF Tumor Necrosis Factor 57 YONDELIS 57 leukemia AML 57 selective phosphodiesterase 57 Kinase Inhibitor 57 HuLuc# 57 Monoclonal antibody 57 CYC# 57 JAK3 57 REVIVE Diabetes 56 MTP inhibitor 56 generation purine nucleoside 56 tyrosine kinase inhibitor 56 CA4P 56 Preclinical studies suggest 56 XL# XL# 56 EOquin TM phase 56 BCR ABL inhibitors 56 HMG CoA reductase inhibitors 56 apoptosis inducer 56 SERMs 56 PrevOnco 56 Vandetanib 56 p# MAPK 56 Panzem R 56 sorafenib tablets 56 mTOR inhibitors 56 TRPV1 agonist 56 5 HT6 56 matrix metalloproteases 56 receptor agonists 56 HGS ETR1 mapatumumab 56 cyclin dependent kinase 56 JAK2 inhibitor 56 OMP #R# 56 Aplidin R 56 IAP inhibitors 56 Cannabinor 56 VQD 56 Protein Kinase C 56 cortisol receptor 56 metastatic androgen independent 56 RTP #i 56 IgG1 monoclonal antibody 56 Saxagliptin 56 5 lipoxygenase 56 RhuDex TM 56 Pradefovir 56 vinca alkaloid 56 PS# [001] 56 Bafetinib 56 COX2 56 selectively inhibit 56 perifosine novel potentially 56 MGd 56 antisense drug 56 anionic backbone 56 HIV integrase inhibitors 56 kinase inhibition 56 small molecule thrombopoietin 56 Pertuzumab 56 novel anticancer 56 itraconazole Sporanox 56 phase IIa clinical 56 Trastuzumab DM1 56 RNA antagonists 56 XL# XL# XL# XL# 56 Ambrisentan 56 cytotoxic T lymphocyte 56 relapsed MM 56 Angiotensin Converting Enzyme 56 prostacyclin receptor 56 TBC# 56 anti mitotic 56 Ixabepilone 56 GLPG# 56 Hsp# Inhibitor 56 eotaxin 56 Phase Ib II 56 5 HT3 receptor 56 ocrelizumab 56 Daclizumab 56 polymerase inhibitors 56 HCV polymerase 56 Nexavar ® 56 IGF IR 56 TELINTRA 56 long acting muscarinic 56 CRAC channel 56 humanized anti 56 acyclovir Lauriad R 56 ofatumumab HuMax CD# 56 vaccines oncolytic virus 56 TRIOLEX ™ 56 Zolinza 56 CEA CD# Her2 56 PI3K/Akt pathway 56 LY# [002] 56 NXL# 56 selective androgen receptor modulator 56 OncoVex 56 mertansine 56 developing Bicifadine serotonin 56 Deforolimus 56 Hsp# inhibition 56 multikinase inhibitor 56 phase Ib 56 ATL/TV# 56 isoform selective 56 VitiGam 56 5 HT4 receptor 56 M2 subunit 56 VEGF receptor 56 polycythemia vera essential thrombocythemia 56 potent antiproliferative 56 Ceflatonin 56 blinded randomized placebo controlled 56 ALN TTR 56 CDK inhibitor 56 Amplimexon 56 Eg5 56 phase IIb clinical 56 atacicept 56 PI3K inhibitors 56 fusion inhibitors 56 Bezielle 56 PSMA ADC 56 XmAb# 56 Peginterferon alfa 2b 56 Kahalalide F 56 pharmacogenomic translational research 56 Muraglitazar 56 mTOR inhibitor 56 5 HT2B receptor 56 oncolytic 56 EOquin 56 HCV NS3 protease 56 targeted radiotherapeutic 56 Voreloxin 56 small molecule glucokinase 56 semi synthetic lipoglycopeptide 56 Zoraxel TM 56 Ostabolin C TM 56 novel immunomodulatory 56 Pathway Inhibitor 56 cytokine refractory 56 c Raf kinase 56 TAFA# 56 molecularly targeted 56 torezolid phosphate 56 hormone LHRH antagonist 56 CRTH2 56 Hedgehog signaling pathway 56 Raf MEK ERK 56 histone methyltransferases HMTs 56 Denufosol 56 miconazole Lauriad R 56 nucleoside analogues 56 protein tyrosine phosphatases 56 recurrent glioblastoma multiforme 56 Avanafil 56 gamma secretase inhibitor 56 anti secretory 56 PARP inhibitors 56 novel therapeutic antibodies 56 plus prednisone prednisolone 56 CML CP 56 HCV polymerase inhibitor 56 Cobalamin TM mediated 56 immunotherapeutic agent 56 pomalidomide 56 Orally administered 56 induces apoptosis 56 CBLC# 56 Virulizin ® 55 renin inhibitors 55 PEG SN# 55 CG# [003] 55 tumor xenograft models 55 anidulafungin 55 mitogen activated protein kinase 55 TACI Ig 55 agonist compounds 55 Anidulafungin 55 relapsed refractory 55 selective agonist 55 Phosphodiesterase 55 Tesmilifene 55 preclinically 55 cMET 55 Imatinib mesylate 55 Elagolix 55 Darusentan 55 ALK inhibitors 55 Xeloda ® 55 systemic ALCL 55 Plicera 55 diarrhea predominant irritable 55 JZP 55 renin inhibitor 55 forodesine 55 Dapagliflozin 55 Initiate Phase 55 #HT#A 55 S/GSK# 55 immune modulating 55 bortezomib Velcade R 55 2 methoxyestradiol 55 transient receptor 55 PSN# [001] 55 nucleotide reverse transcriptase 55 small molecule chemotherapeutic 55 PEGylated docetaxel 55 Onconase 55 Phase 2b clinical trials 55 farletuzumab 55 Flt3 55 vinblastine 55 immunomodulating 55 potent anticancer 55 ribonucleotide reductase clinically validated 55 elacytarabine 55 androgen receptor antagonist 55 APOPTONE 55 includes AstraZeneca Accolate 55 kinase inhibitor 55 mapatumumab 55 CORT # 55 pediatric Crohn disease 55 TNFα 55 synthetic cannabinoid compounds 55 inhibit replication 55 polysaccharide polymer 55 essential thrombocythemia ET 55 androgen independent 55 Traficet EN 55 agents Tabun Sarin 55 pradefovir 55 Oracea TM 55 inhibits protein synthesis 55 soluble epoxide hydrolase 55 5 HT2A 55 antiapoptotic 55 geldanamycin 55 angiogenesis inhibitors 55 maximally tolerated dose 55 MEK1 55 Gleevec resistant 55 echinocandins 55 protein kinase inhibitors 55 drug pipeline TAFA# 55 Exherin TM 55 amrubicin 55 CD# CEA 55 nucleotide analog 55 EGF receptor 55 reslizumab 55 small molecule VR1 55 thalidomide Thalomid 55 Nanobody 55 evaluating satraplatin 55 Arranon 55 leukocyte adhesion 55 Luteinizing Hormone Releasing Hormone 55 thyroid hormone receptor 55 induce apoptosis 55 epigenetic therapies 55 Pruvel 55 glycogen synthase kinase 55 heavily pretreated 55 aurora kinase inhibitor 55 cytostatic 55 cannabinor 55 Pharmos pipeline 55 PKC# 55 microRNA antagonists 55 tyrosine kinase inhibitors 55 Mipomersen 55 NS4A 55 Lixivaptan 55 Troxatyl 55 factor Xa 55 Bruton tyrosine kinase Btk 55 CCX# B 55 Hematide ™ 55 tumor antigen 55 mGluR4 55 PTP1B 55 phosphatidylinositol 3 55 oral candidiasis 55 mGluR2 positive 55 glucagon receptor 55 oral anticancer 55 Lu AA# 55 ATRA IV 55 Factor Receptor 55 orally dosed 55 TLR9 agonist 55 p# mitogen activated 55 M# rationally 55 Vilazodone 55 potently inhibits 55 nilotinib Tasigna 55 DNA intercalator 55 SYN# 55 hypereosinophilic syndrome 55 defensin mimetic antibiotic 55 PLX MS 55 SAR# [002] 55 positive allosteric modulator 55 mda 7 55 FUSILEV enhances 55 romidepsin 55 torsemide ER 55 Randomized Phase 55 p# alpha [001] 55 Albuferon albinterferon alfa 2b 55 Tasimelteon 55 p# inhibitor 55 Kevetrin ™ 55 Factor VIIa 55 integrase inhibitor 55 selective orally bioavailable 55 aldehyde dehydrogenase ALDH2 deficiency 55 thiazolidinediones TZDs 55 ALN HPN 55 doxorubicin cyclophosphamide 55 selective androgen receptor modulators 55 histone deacetylases 55 treatment naive genotype 55 CYP #A# 55 sphingosine kinase 55 Triapine R 55 sodium glucose transporter 55 baminercept 55 investigational oral 55 huN# DM1 55 idarubicin 55 motesanib diphosphate 55 insulin sensitizers 55 selective inhibition 55 Pazopanib 55 adrenergic regulation 55 Olaparib 55 platelet aggregation inhibitors 55 JAK3 inhibitor 55 psoriasis rheumatoid arthritis 55 PDGF receptor 55 posaconazole 55 Linaclotide 55 bortezomib Velcade 55 Exelixis compounds 55 HCV nucleoside 55 proliferator activated receptor 55 BAY #-# 55 retinoic acid receptor 55 echinocandin 55 Sym# 55 CCR5 receptor antagonists 55 DPP4 inhibitor 55 ospemifene 55 HMG CoA reductase 55 Plecanatide 55 huC# DM4 55 HDAC inhibitor 55 anticancer therapies 55 rNAPc2 55 mGluR2 55 relapsed leukemia 55 sPLA2 55 irreversible inhibitor 55 Spiegelmer ® 55 TRO# 55 PTHrP 55 oral dual endothelin 55 c MYC 55 factor TNF 55 vosaroxin 55 reverse transcriptase inhibitors 55 5 hydroxytryptamine 55 cancer immunotherapies 55 KRN# 55 erlotinib Tarceva R 55 Pimavanserin 55 depsipeptide 55 NS3 protease 55 alemtuzumab Campath 54 PDE#A 54 DG# compounds targeting 54 entinostat 54 therapeutic monoclonal antibody 54 systemically administered 54 allosteric modulator NAM 54 oncolytic virus therapies 54 Teriflunomide 54 Cloretazine ® 54 immunomodulatory 54 bexarotene 54 anticancer therapeutics 54 OMNARIS HFA 54 T#I [002] 54 ProMune 54 Akt inhibitor 54 PRTX 54 Genz # 54 potent inhibition 54 cyclooxygenase COX 54 drug conjugate 54 radezolid 54 azoles 54 lamotrigine Lamictal 54 ceftazidime 54 novel emulsion formulation 54 alpha 2b 54 mu opioid receptor antagonist 54 dextromethorphan quinidine 54 multiple myeloma MM 54 integrase inhibitors 54 antiangiogenic agent 54 BN# [002] 54 Squalamine 54 ZACTIMA 54 tyrosine kinase inhibitor TKI 54 AEGR 54 Guanilib 54 hedgehog pathway 54 R sorafenib tablets 54 candidate AQ4N 54 opioid receptor antagonist 54 SPC# [001] 54 inhibitors 54 5HT 54 CIMZIA TM 54 Phase #/#a trial 54 EGFR HER2 54 dacetuzumab 54 Dasatinib 54 protein mTOR 54 Delafloxacin 54 tumor vascular disrupting 54 Alzhemed TM 54 thrombin receptor 54 2A receptor agonist 54 thiazolidinedione TZD 54 TLR8 54 NNRTIs 54 modulate ion channel 54 Myelodysplastic Syndrome MDS 54 relapsed refractory multiple myeloma 54 BRIM3 54 SAR# [004] 54 generation PNP inhibitor 54 metastatic hormone refractory 54 Curaxin CBLC# 54 Phase Ib clinical 54 TNF α 54 investigational protease inhibitor 54 regorafenib 54 ketolide antibiotic 54 LPA1 receptor 54 dihydrofolate reductase DHFR 54 BiTE ® 54 PI3K Akt 54 chemically modified siRNA 54 imatinib Gleevec 54 R#/MEM # 54 Aurora kinases 54 CD8 + cytotoxic 54 GSK# [001] 54 antibody MT# 54 incyclinide 54 PXD# 54 Phase 2b Clinical Trial 54 cladribine Cladribine Tablets 54 selectively modulating 54 biologic DMARD 54 Tumour Necrosis Factor 54 lesinurad 54 Sphingosine 1 54 staphylococcal vaccine 54 erlotinib Tarceva 54 DEB# 54 TNFalpha 54 GLP toxicology studies 54 mRNA antagonist 54 GRNVAC1 54 CCR1 54 riociguat 54 axitinib 54 Neuvenge 54 biased ligand 54 partial agonist 54 myeloproliferative diseases 54 selective estrogen receptor modulators 54 torezolid 54 DMAG 54 ANAVEX #-# [001] 54 OvaRex R 54 c MET 54 oral ridaforolimus 54 siRNA therapeutics 54 bone metastasis 54 brivaracetam 54 lumiliximab 54 nelfinavir Viracept 54 XmAb ® 54 anticancer agent 54 targeted antifolate 54 octreotide implant 54 TELCYTA 54 TG# [003] 54 mg q#h 54 anti angiogenic agent 54 serine protease 54 Testosterone MDTS R 54 sitaxsentan 54 blockbuster Januvia 54 Vicriviroc 54 cholesteryl ester transfer 54 CTLA 4 54 Tesetaxel 54 fusion enhancers 54 Pharmacokinetics PK 54 mediated inhibition 54 oral immunomodulatory 54 Factor VEGF 54 tiapamil 54 T#I mutant 54 Contrave# 54 registrational 54 immunotoxin 54 antitumoral 54 CLL SLL 54 neuronal nicotinic receptor NNR 54 Amrubicin 54 vanilloid receptor 54 DFMO 54 ocular formulation 54 bosutinib 54 HQK 54 candidate CRLX# 54 Phase #b/#a trial 54 acadesine 54 Tarvacin 54 GRNOPC1 contains 54 A3 adenosine receptor 54 antagonist LAMA 54 compound ITMN 54 retaspimycin hydrochloride 54 Bicifadine 54 N acetylgalactosamine 6 54 anti fibrotic 54 antitumor 54 Lucanix R 54 PARP inhibitor 54 immunomodulator 54 AVEO integrates proprietary 54 DHODH 54 Smac mimetic 54 GSK3B 54 Critical Therapeutics Zyflo 54 volociximab 54 ELACYT 54 COPEGUS R 54 selective adenosine 54 Zybrestat 54 nicotinic 54 tipifarnib 54 miconazole Lauriad ® 54 Dr. Aiping Young 54 Fx #A 54 serotonin norepinephrine reuptake inhibitors 54 VBL proprietary